Rxcurve
HCPCS J9070 · per 100 MG

Cyclophosphamide 100 mg inj

This code is not in the latest file (4Q26). It was last listed in 1Q24.

Payment limit per 100 MG, by effective quarter, 1Q21 to 1Q24. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9070

No NDCs mapped to this code in the 4Q26 crosswalk.

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
1Q24 $20.153 +$2.211 100 MG Cyclophosphamide 100 mg inj v1, posted December 19, 2024
4Q23 $17.942 +$0.855 100 MG Cyclophosphamide 100 mg inj v1, posted October 10, 2024
3Q23 $17.087 −$4.55 100 MG Cyclophosphamide 100 mg inj v1, posted June 5, 2024
2Q23 $21.637 −$0.494 100 MG Cyclophosphamide 100 mg inj v1, posted February 23, 2024
1Q23 $22.131 +$0.208 100 MG Cyclophosphamide 100 mg inj v1, posted December 6, 2023
4Q22 $21.923 −$4.947 100 MG Cyclophosphamide 100 mg inj v1, posted June 22, 2023
3Q22 $26.87 +$2.99 100 MG Cyclophosphamide 100 mg inj v1, posted June 9, 2023
2Q22 $23.88 −$3.593 100 MG Cyclophosphamide 100 mg inj v1, posted December 14, 2022
1Q22 $27.473 −$1.68 100 MG Cyclophosphamide 100 mg inj v1, posted June 8, 2022
4Q21 $29.153 −$1.844 100 MG Cyclophosphamide 100 mg inj v1, posted June 2, 2022
3Q21 $30.997 +$0.109 100 MG Cyclophosphamide 100 mg inj v1, posted June 2, 2022
2Q21 $30.888 −$0.276 100 MG Cyclophosphamide 100 mg inj v1, posted March 1, 2022
1Q21 $31.164 – 100 MG Cyclophosphamide 100 mg inj v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files